Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Feb 7, 2008; 14(5): 685-692
Published online Feb 7, 2008. doi: 10.3748/wjg.14.685
Published online Feb 7, 2008. doi: 10.3748/wjg.14.685
Figure 8 Adoptive immunotherapy in HCC.
Autologous lymphocytes activated in vitro with recombinant interleukin-2 and infused five times during the first month. Adoptive immunotherapy reduces recurrence and improves recurrence-free survival after surgery for HCC. Takayama et al. Lancet 2000.
- Citation: Yamazaki S, Takayama T. Surgical treatment of hepatocellular carcinoma: Evidence-based outcomes. World J Gastroenterol 2008; 14(5): 685-692
- URL: https://www.wjgnet.com/1007-9327/full/v14/i5/685.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.685